|
Atezolizumab plus carboplatin: A winning combination for metastatic triple-negative b
Immunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastatic breast cancer.
More... |
| All times are GMT -7. The time now is 10:58 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021